Equibles does not estimate personal net worth.
Get an email with a short summary when Pediatrix Medical Group, Inc. publishes a filing, an earnings call transcript or a press release.
Get MD alertsKasandra Rossi is recorded as CFO at Pediatrix Medical Group, Inc. (MD). The newest filing on record that lists Kasandra Rossi as CFO at Pediatrix Medical Group, Inc. (MD) is dated March 27, 2026. Pediatrix Medical Group, Inc. reported in an 8-K filed August 6, 2024 that Kasandra Rossi was appointed Executive Vice President, Chief Financial Officer and Treasurer, effective October 1, 2024. The proxy statement of Pediatrix Medical Group, Inc. reports total compensation of $1,860,037 for Kasandra Rossi in fiscal 2025, including a base salary of $437,500. Disclosed compensation is on record for 2 fiscal years. Kasandra Rossi has spoken on 9 earnings calls across 1 company, most recently for Pediatrix Medical Group, Inc. on October 29, 2026. Pediatrix Medical Group, Inc. is classified in the Medical Care Facilities industry within the Healthcare sector. Other leadership on record at Pediatrix Medical Group, Inc. includes James D. Swift, M.D. (CEO, COO and Board Member), Mark S. Ordan (CEO and Chairman), Guy P. Sansone (Chairman and Board Member) and 7 others.
“On August 6, 2024, the Company announced that its board of directors (the "Board") has appointed Ms. Kasandra Rossi, who currently serves as the Company's Senior Vice President, Financial Reporting and Assistant Treasurer, to succeed Mr. C. Marc Richards as Executive Vice President, Chief Financial Officer ("CFO") and Treasurer of the Company.”
“Our consolidated revenue increased by just under 2%, driven by non-same unit activity, primarily recent acquisitions, and same unit growth of 60 basis points.”
“Now I'll turn the call to Cassandra to provide those additional details. thanks mark and good morning everyone our consolidated revenue increased by four percent driven by non-same unit activity primarily recent acquisitions and same unit growth of two percent same unit pricing was up four percent driven by strong rcm…”
“Our consolidated revenue increase was driven by same-unit growth of just under 3%, and net non-same unit activity of about $6 million, dollars, including growth from recent acquisitions and organic growth, which was partially offset by decreases in revenue from our portfolio restructuring.”
“One, our consolidated revenue decrease was driven by net non-same unit activity of $26 million, including a decrease in revenue from our portfolio restructuring, partially offset by an increase in revenue from acquisition and organic growth.”
“This is definitely not my real voice, so please forgive me. Our consolidated revenue decrease was driven by our portfolio restructuring activity of just under $54 million.”
Start not stated–present
Last confirmed March 27, 2026
Medical Care Facilities · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pediatrix Medical Group, Inc. (MD) | Executive Vice President, Chief Financial Officer & Treasurer | $437,500 | $1,860,037 |
| 2024 | Pediatrix Medical Group, Inc. (MD) | Executive Vice President, Chief Financial Officer & Treasurer | $368,750 | $1,344,756 |
